| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.033 | 0.9 |